Zasocitinib

STOCKHOLM, Sweden, June 11OSAKA, Japan and CAMBRIDGE, Massachusetts, June 11, 2026, 2026 Takeda has announced positive topline results from...

OSAKA, Japan and CAMBRIDGE, Mass., March 28, 2026 Takeda announced positive results from its Phase 3 LATITUDE clinical trials...